Results 101 to 110 of about 6,483 (201)

Haematopoietic stem cell transplantation for cutaneous T‐cell lymphomas: Decision‐guiding prognostic determinants yet to be clarified

open access: yes
Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 1, Page 23-24, January 2026.
Marion Wobser
wiley   +1 more source

Single-cell heterogeneity in Sézary syndrome

open access: yesBlood Advances, 2018
: Sézary syndrome (SS) is an aggressive leukemic variant of cutaneous T-cell lymphoma (CTCL) with a median life expectancy of less than 4 years. Although initial treatment responses are often good, the vast majority of patients with SS fail to respond to
Terkild Brink Buus   +19 more
doaj   +1 more source

Reactive Langerhans Cell Proliferation Mimicking Langerhans Cell Histiocytosis in Association with Sézary Syndrome: A Case Report and Literature Review

open access: yesClinical, Cosmetic and Investigational Dermatology, 2021
Jinjing Zhang,1 Shiyu Ma,1 Jinxiang Yu,1 Song Zheng,2 Yuan Miao,3 Pingping Wang,1 Xiaojing Yan1 1Department of Hematology, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning, 110001, People’s Republic of China; 2Department of ...
Zhang J   +6 more
doaj  

Adult T-cell leukemia-lymphoma in a patient with HTLV-I/II associated myelopathy Leucemia - linfoma de células T do adulto em um paciente com mielopatia associada a HTLV-I/II

open access: yesArquivos de Neuro-Psiquiatria, 1997
Chronic myelopathy associated with T-lymphotropic virus type I (HAM) has been described as an endemic disease in several areas of the world, meanwhile there are few papers describing the association between HAM and adult T cell leukemia-lymphoma.
Virgínia Freitas   +4 more
doaj   +1 more source

Novel cell adhesion/migration pathways are predictive markers of HDAC inhibitor resistance in cutaneous T cell lymphoma [PDF]

open access: yes, 2019
BACKGROUND: Treatment for Cutaneous T Cell Lymphoma (CTCL) is generally not curative. Therefore, selecting therapy that is effective and tolerable is critical to clinical decision-making. Histone deacetylase inhibitors (HDACi), epigenetic modifier drugs,
Andrews, Jared M   +5 more
core   +2 more sources

SEZARY SYNDROME [PDF]

open access: yesMedical Journal Armed Forces India, 1998
RAMJI RAI, R LAKHTAKIA
openaire   +1 more source

Pre-sezary To Sezary Erythroderma Syndrome.

open access: yesIndian journal of dermatology, venereology and leprology, 2012
A 50-year old woman was admitted with pre-Se'zary syndrome in May, 97 as she had intractable progressive erythroderma with intense pruritus since 15 months. She also had axillary, inguinal, hilar and para-aortic lymphadenopathy, hepatomegaly, alopecia, hypersensitivity to cefadroxyl, and abnormal Sezary cells in peripheral blood film.
R R, Mittal, P S, Sethi
openaire   +1 more source

Report of the Symposium on Cutaneous Lymphomas: Sixth International Conference on Malignant Lymphoma [PDF]

open access: yes, 2017
The symposium discussed the pathobiology, classification, and treatment of cutaneous lymphomas. Drs. Burg and Kadin commented on the pathophysiology of mycosis fungoides/Sézary syndrome and cutaneous CD30+ lymphoproliferative disorders, respectively.
Burg, G., Jaffe, E. S.
core  

[Sezary's syndrome (case report)].

open access: yesSrpski arhiv za celokupno lekarstvo, 2006
The Sezary's syndrome is a lymphoproliferative disorder from the group of chronical lymphocytic leukaemia originated from the T-cell lineage. Authors are presenting the patient with Sezary's syndrome for the first time ever diagnosed in the Institute of Haematology. The patient, 58 years old got ill in summer 1989.
N, Miscević   +5 more
openaire   +1 more source

Quantification and expert evaluation of evidence for chemopredictive biomarkers to personalize cancer treatment. [PDF]

open access: yes, 2017
Predictive biomarkers have the potential to facilitate cancer precision medicine by guiding the optimal choice of therapies for patients. However, clinicians are faced with an enormous volume of often-contradictory evidence regarding the therapeutic ...
Beckman, Robert A.   +8 more
core   +1 more source

Home - About - Disclaimer - Privacy